Literature DB >> 7679587

Cytokine production by peripheral blood monocytes and T cells during haemopoietic recovery after intensive chemotherapy.

Y Takamatsu1, K Akashi, M Harada, T Teshima, S Inaba, K Shimoda, T Eto, T Shibuya, S Okamura, Y Niho.   

Abstract

We studied the production of cytokines by peripheral blood monocytes and T cells during the period of haematological recovery following intensive chemotherapy. Twelve adults with haematological malignancies received consolidation chemotherapy of complete remission. Monocytes and T cells were collected during the phase of recovery from intensive chemotherapy, and were incubated for 24 h in a culture medium with 10% FCS. Concentrations of cytokines in the culture supernatant were measured with an enzyme-linked immunosorbent assay. During the recovery phase, concentrations of IL-6, G-CSF and IL-1 beta in the culture supernatant of the collected monocytes significantly exceeded those of the monocytes obtained from normal healthy subjects. Similarly, the concentrations of GM-CSF and IFN-gamma in the supernatant of recovery phase T cells significantly exceeded those of normal T cells. Plasma levels of these cytokines were also elevated. These data suggest that the monocytes and T cells may be activated in vivo to produce haemopoietic cytokines during haematological recovery, and that, during haematological recovery, the monocytes and T cells may be actively involved in the induction of haematopoiesis following the myelosuppression induced by chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679587     DOI: 10.1111/j.1365-2141.1993.tb04625.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Surface phenotype analysis of CD16+ monocytes from leukapheresis collections for peripheral blood progenitors.

Authors:  M Tanaka; J Honda; Y Imamura; K Shiraishi; K Tanaka; K Oizumi
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 2.  Graft failure due to hemophagocytic syndrome after autologous peripheral blood stem cell transplantation.

Authors:  K Fukuno; H Tsurumi; T Yamada; M Oyama; H Moriwaki
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

3.  A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation.

Authors:  Ivar Østby; Leiv S Rusten; Gunnar Kvalheim; Per Grøttum
Journal:  J Math Biol       Date:  2003-04-23       Impact factor: 2.259

4.  Novel method for detection of ex vivo tumor necrosis factor alpha production by monocytes.

Authors:  Kikumi Suzuki; Takatoshi Koyama; Shizuko Kobayashi; Koji Kobayashi; Koji Inagaki; Yoshiko Abe; Kiyoshi Kuriyama; Kiyoko Shiba
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

5.  An endothelial proinflammatory phenotype precedes the development of the engraftment syndrome after autologous Hct.

Authors:  Ana Belén Moreno-Castaño; Marta Palomo; Sergi Torramadé-Moix; Julia Martinez-Sanchez; Alex Ramos; Patricia Molina; Marc Pino; Pilar Gómez-Ramírez; Laura Bonastre; Maria Teresa Solano; Ginés Escolar; Montserrat Rovira; Luis Gerardo Rodríguez-Lobato; Gonzalo Gutiérrez-García; Enric Carreras; Francesc Fernández-Avilés; Maribel Diaz-Ricart
Journal:  Bone Marrow Transplant       Date:  2022-02-18       Impact factor: 5.483

6.  Endothelial cells are main producers of interleukin 8 through Toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients.

Authors:  C S M Oude Nijhuis; E Vellenga; S M G J Daenen; W A Kamps; E S J M De Bont
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

7.  Pre-engraftment syndrome in hematopoietic stem cell transplantation.

Authors:  Young-Ho Lee; Yeon-Jung Lim; Jung-Yun Kim; Young-Dae Kim; Seung-Won Lee
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153

8.  Impact of interstitial pneumonia on the survival and risk factors analysis of patients with hematological malignancy.

Authors:  Wei-Liang Chen; Yu-Tzu Tsao; Tsun-Hou Chang; Tsu-Yi Chao; Woei-Yau Kao; Yeu Chin Chen; Ching-Liang Ho
Journal:  Biomed Res Int       Date:  2013-09-04       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.